Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.62

+0.03 (+4.24%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,207.3% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $0.62

Current
$0.62

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

717.9%

Low target

Base Case

$8.04

+1,207.3%

Avg target

Bull Case

$9.33

+1,417.1%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$8.58

-92.8% from high

52-Week Low

$3.93

+-84.4% from low

Target vs 52W High

$8.04

-6.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%